Clarametyx Biosciences
PrivateLast Round
Series A
Extension
Aug 4, 2025
Total Funding Raised
$55.59M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Clarametyx Biosciences is a biotechnology company that develops immune-enabling biologic therapies and vaccines targeting bacterial biofilms to treat severe persistent infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Clarametyx Biosciences Comparables
Compare Clarametyx Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Trellis Bioscience | 81% | |
| Peptilogics | 79% | |
| Centauri Therapeutics Limited | 77% |
Clarametyx Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Aug 4, 2025 | ||||
| Series A Extension | May 1, 2025 | ||||
| Grant | Jan 7, 2025 | ||||
| Series A | Jan 5, 2024 | ||||
| Grant | Apr 4, 2022 | ||||
Convertible Debt | Aug 31, 2021 |
Clarametyx Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CARB-X | Grant |
| Kineticos Ventures | Grant |
| CincyTech | Series A Extension |
| Cystic Fibrosis Foundation | Series A |
| Rev1 Ventures | Seed, Series A |
| Ohio Innovation Fund | Series A |
| JobsOhio | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 59% MoM.
- May 1, 2025
Raised Series A Extension with CincyTech and kineticos-amr-accelerator-fund-i.
Clarametyx Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Clarametyx Biosciences's valuation, stock price, and market status.
Is Clarametyx a public or private company?
Clarametyx is a private company.
What is the current stock price of Clarametyx?
Clarametyx is a private company with no public stock price. No recent secondary market data is available.
How much is Clarametyx worth (valuation)?
Valuation information for Clarametyx is not publicly available.
Can I buy Clarametyx stock?
Clarametyx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Clarametyx's last funding round?
Clarametyx's most recent funding round was Series A Extension on August 4, 2025.
Who are the main investors in Clarametyx?
Key investors in Clarametyx include Rev1 Ventures, Ohio Innovation Fund.
Will Clarametyx IPO soon?
No public IPO plans have been announced for Clarametyx.
How can I track Clarametyx secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Clarametyx's secondary market activity and sign up for updates.